Literature DB >> 25589553

Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.

Jenny Herbert1, Stephen Thomas1, Charlotte Brookes1, Claudia Turner2, Paul Turner2, Francois Nosten3, Kirsty Le Doare4, Michael Hudson1, Paul T Heath5, Andrew Gorringe1, Stephen Taylor6.   

Abstract

Streptococcus agalactiae (group B streptococcus [GBS]) is the leading cause of neonatal sepsis and meningitis. In this study, we determined antibody-mediated deposition of complement C3b/iC3b onto the bacterial cell surface of GBS serotypes Ia, Ib, II, III, and V. This was determined for 520 mother and umbilical cord serum sample pairs obtained at the time of birth from a population on the Thailand-Myanmar border. Antibody-mediated deposition of complement C3b/iC3b was detected to at least one serotype in 91% of mothers, despite a known carriage rate in this population of only 12%. Antibody-mediated C3b/iC3b deposition corresponded to known carriage rates, with the highest levels of complement deposition observed onto the most prevalent serotype (serotype II) followed by serotypes Ia, III, V, and Ib. Finally, neonates born to mothers carrying serotype II GBS at the time of birth showed higher antibody-mediated C3b/iC3b deposition against serotype II GBS than neonates born to mothers with no serotype II carriage. Assessment of antibody-mediated C3b/iC3b deposition against GBS may provide insights into the seroepidemiology of anti-GBS antibodies in mothers and infants in different populations.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25589553      PMCID: PMC4340890          DOI: 10.1128/CVI.00803-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  46 in total

Review 1.  Phagocytosis: measurement by flow cytometry.

Authors:  A K Lehmann; S Sornes; A Halstensen
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

Review 2.  Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.

Authors:  R A Fleck; S Romero-Steiner; M H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Clonal variability of group B Streptococcus among different groups of carriers in southern Israel.

Authors:  D Marchaim; S Efrati; R Melamed; L Gortzak-Uzan; K Riesenberg; R Zaidenstein; F Schlaeffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

4.  Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Authors:  M S Edwards; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

Review 5.  Haemophilus influenzae and the complement system.

Authors:  Teresia Hallström; Kristian Riesbeck
Journal:  Trends Microbiol       Date:  2010-06       Impact factor: 17.079

6.  Development of a large scale human complement source for use in bacterial immunoassays.

Authors:  Charlotte Brookes; Eeva Kuisma; Frances Alexander; Lauren Allen; Thomas Tipton; Sanjay Ram; Andrew Gorringe; Stephen Taylor
Journal:  J Immunol Methods       Date:  2013-02-26       Impact factor: 2.303

7.  A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group B Streptococcus.

Authors:  Hilde-Kari Guttormsen; Samantha J Mascuch; Julia C West; Lawrence C Paoletti
Journal:  Hum Vaccin       Date:  2009-07-10

8.  Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.

Authors:  Catherine Hyams; Krzysztof Trzcinski; Emilie Camberlein; Daniel M Weinberger; Suneeta Chimalapati; Mahdad Noursadeghi; Marc Lipsitch; Jeremy S Brown
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

9.  Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border.

Authors:  Claudia Turner; Paul Turner; Linda Po; Naw Maner; Aruni De Zoysa; Baharak Afshar; Androulla Efstratiou; Paul T Heath; François Nosten
Journal:  BMC Infect Dis       Date:  2012-02-08       Impact factor: 3.090

Review 10.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

View more
  4 in total

1.  Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.

Authors:  Jacqueline A Baker; Emma L Lewis; Leah M Byland; Maryam Bonakdar; Tara M Randis; Adam J Ratner
Journal:  Vaccine       Date:  2017-02-02       Impact factor: 3.641

2.  Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.

Authors:  Frances Alexander; Emily Brunt; Holly Humphries; Breeze Cavell; Stephanie Leung; Lauren Allen; Rachel Halkerston; Elodie Lesne; Elizabeth Penn; Stephen Thomas; Andrew Gorringe; Stephen Taylor
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

4.  Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.

Authors:  Kirsty Le Doare; Amadou Faal; Mustapha Jaiteh; Francess Sarfo; Stephen Taylor; Fiona Warburton; Holly Humphries; Jessica Birt; Sheikh Jarju; Saffiatou Darboe; Edward Clarke; Martin Antonio; Ebenezer Foster-Nyarko; Paul T Heath; Andrew Gorringe; Beate Kampmann
Journal:  Vaccine       Date:  2017-04-24       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.